rp11-438n5.3 as a novel biomarker in nsclc - video abstract [id 237024]
Published 4 years ago • 126 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
5:42
dr. leighl shares paloma-3 data on patient experiences with subcutaneous amivantamab
-
4:35
tabrecta - lung cancer treatment
-
1:24
diagnosis: eln recommendations
-
5:44
quest for a cure
-
1:59
dr. lindeman on rationale for a phase ib trial of venetoclax and tamoxifen in breast cancer
-
2:15
the divison of hematology & oncology
-
2:27
namali pierson (md) - oncology
-
6:46
dr. luminari remarks on eu approval of odronextamab for dlbcl, follicular lymphoma
-
4:47
apa itu limfoma ?
-
4:31
the basics about lung cancer
-
1:51
clinical trial at brown cancer center saves lung cancer patient, becomes approved treatment
-
1:52
a cancer medication tune-up
-
1:52
lynn m. schuchter, md -- medical oncologist at penn medicine
-
1:10
bonnie j. addario discusses unmet needs in lung cancer care
-
1:40
jia ruan, m.d., ph.d.
-
3:24
billie remains cancer-free
-
18:19
3-lu
-
1:37
angela jain, md
-
1:33
john diaz, m.d.
-
1:06
targeting tcf3-hlf−positive all
-
3:40
amber lin md family medicine